In this Team Q&A session, Dave Williams, Director, Bioanalytical Operations at BioAgilytix, talks with us about why he made the move from Kansas City to join the BioAgilytix team in 2017, and the ways in which his role has evolved in just one year.
To keep up with the rapidly evolving field of drug development, we must stay on the pulse of bioanalytical innovation. Our latest blog summarizes some of the latest industry articles our team has found noteworthy.
In immunogenicity assessments, we ideally aim to see any drug-induced antibody. Therefore, the best method is one that is able to detect ADAs as sensitively and specifically as possible. We discuss how the Biacore™ T200 platform enables this level of analysis.
Platforms
Services